86
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Biology of Zika Virus Infection in Human Skin Cells.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Zika virus (ZIKV) is an emerging arbovirus of the Flaviviridae family, which includes dengue, West Nile, yellow fever, and Japanese encephalitis viruses, that causes a mosquito-borne disease transmitted by the Aedes genus, with recent outbreaks in the South Pacific. Here we examine the importance of human skin in the entry of ZIKV and its contribution to the induction of antiviral immune responses. We show that human dermal fibroblasts, epidermal keratinocytes, and immature dendritic cells are permissive to the most recent ZIKV isolate, responsible for the epidemic in French Polynesia. Several entry and/or adhesion factors, including DC-SIGN, AXL, Tyro3, and, to a lesser extent, TIM-1, permitted ZIKV entry, with a major role for the TAM receptor AXL. The ZIKV permissiveness of human skin fibroblasts was confirmed by the use of a neutralizing antibody and specific RNA silencing. ZIKV induced the transcription of Toll-like receptor 3 (TLR3), RIG-I, and MDA5, as well as several interferon-stimulated genes, including OAS2, ISG15, and MX1, characterized by strongly enhanced beta interferon gene expression. ZIKV was found to be sensitive to the antiviral effects of both type I and type II interferons. Finally, infection of skin fibroblasts resulted in the formation of autophagosomes, whose presence was associated with enhanced viral replication, as shown by the use of Torin 1, a chemical inducer of autophagy, and the specific autophagy inhibitor 3-methyladenine. The results presented herein permit us to gain further insight into the biology of ZIKV and to devise strategies aiming to interfere with the pathology caused by this emerging flavivirus.

          Related collections

          Author and article information

          Journal
          J. Virol.
          Journal of virology
          1098-5514
          0022-538X
          Sep 2015
          : 89
          : 17
          Affiliations
          [1 ] Laboratoire MIVEGEC, UMR 224 IRD/CNRS/UM, Montpellier, France.
          [2 ] INSERM, U944, Laboratoire de Pathologie et Virologie Moléculaire, Paris, France.
          [3 ] Centre d'Étude d'Agents Pathogènes et Biotechnologies pour la Santé, CNRS-UMR 5236/UM, Montpellier, France.
          [4 ] Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
          [5 ] Pathology Department, Prince of Songkla University, Songkla, Thailand.
          [6 ] Institut Louis Malardé, Papeete, Tahiti, French Polynesia.
          [7 ] Environment and Infectious Risks Unit, Institut Pasteur, Paris, France.
          [8 ] Département Infections et Epidémiologie, Institut Pasteur, Paris, France, and UMR PIMIT (I2T Team), Université de La Réunion, INSERM U1187, CNRS 9192, IRD 249, GIP-CYROI, Saint Clotilde, La Réunion, France.
          [9 ] Centre d'Immunologie et des Maladies Infectieuses, INSERM, U1135, Sorbonne Universités, UPMC, APHP Hôpital Pitié-Salpêtrière, Paris, France.
          [10 ] Laboratoire MIVEGEC, UMR 224 IRD/CNRS/UM, Montpellier, France dorothee.misse@ird.fr.
          Article
          JVI.00354-15
          10.1128/JVI.00354-15
          26085147
          b831d970-666f-4813-8098-aceccec366f7
          Copyright © 2015, American Society for Microbiology. All Rights Reserved.
          History

          Comments

          Comment on this article